What is Cone Bioproducts?
Cone Bioproducts is a third-generation family business renowned for its specialization in manufacturing essential components for the diagnostic industry. Their product portfolio includes quality controls, calibrators, verification panels, and proficiency specimens, vital for ensuring accuracy and reliability in diagnostic testing. Serving the In Vitro Diagnostics (IVD) market, the company offers a comprehensive range of biological materials, including processed human serum, purified lipids, and animal bioproducts. Cone Bioproducts also excels in providing contract manufacturing and custom control manufacturing services, enabling bespoke solutions for product development. Their deep expertise in supplying biological components supports IVD manufacturers in accelerating their product development cycles with high-quality, tailored solutions.
How much funding has Cone Bioproducts raised?
Cone Bioproducts has raised a total of $413K across 2 funding rounds:
Debt
$150K
Debt
$263K
Debt (2020): $150K with participation from PPP
Debt (2021): $263K led by PPP
What's next for Cone Bioproducts?
As a company operating within the large-scale late-stage funding environment, Cone Bioproducts is poised for strategic advancements. The recent major strategic investment suggests a focus on scaling operations, enhancing research and development capabilities, or expanding market reach. Given its established position as a family business with decades of experience, this capital infusion is likely to fortify its competitive edge in the IVD market, potentially leading to new product innovations or strategic partnerships. The company's ability to offer custom manufacturing services, combined with its extensive experience in biological components, positions it well for future growth and consolidation within the diagnostic supply chain.
See full Cone Bioproducts company page
